Learn about MET…effective medical treatment that may help you avoid surgery for your stones. MET is focused on using oral drugs/medication to help eliminate, or pass, the stones from the ureters with less pain and complications for the patient, and with a better success rate. This is particularly true for those stones that are located near the bladder. By using drugs to help pass ureteral stones, there is a better chance to avoid surgery, so a careful examination of the science and research is worthwhile. Click here to read the science behind the research.
About Dornier MedTech – Dornier MedTech, a wholly-owned subsidiary of Accuron Medical Technology group (www.accuron.com), is a medical device company focused on providing leading technology and improving life by delivering scientifically superior products and solutions to physicians and patients involved in urological care. As pioneers of the lithotripsy and a variety of surgical lasers, Dornier’s 40 years of innovation and service has made it one of the most trusted MedTech companies in the industry. Dornier MedTech is headquartered in Munich, Germany with offices and distributors all over the world. For more information, visit www.dornier.com.
About the Accuron Medical Technology Group – The Accuron Medical Technology Group is a privately owned by Temasek Holdings, through the business of Dornier MedTech GmbH, Veredus Laboratories and Advanced Materials Technologies Pte Ltd, provide therapeutic, diagnostic, and medical device manufacturing solutions to customers around the globe. Veredus Laboratories Pte Ltd, specializes in the development, manufacture, and marketing of innovative molecular diagnostic solutions in the clinical, specialty, and custom testing markets based on a proprietary Lab-on-Chip platform. Advanced Materials Technologies Pte Ltd serves the contract manufacturing needs of the medical technology sector through providing materials expertise and high precision engineering capabilities.